Literature DB >> 4032439

Preparation of biologically active ristocetin derivatives: replacements of the 1'-amino group.

T R Herrin, A M Thomas, T J Perun, J C Mao, S W Fesik.   

Abstract

A series of ristocetin analogues with modifications (OH, C=O, C=NOH, NCOCH3) at the C-1' amino group was synthesized and found to possess antibacterial activity against gram-positive bacteria and to bind to Ac2-Lys-D-Ala-D-Ala, a model for the antibiotic's site of action. Due to the lack of a positively charged amino group, the active analogues could not form a salt bridge, indicating that an electrostatic interaction between the positively charged 1'-amino group of ristocetin and the carboxylate anion of the peptide is not required for complex formation. The only compound that did not exhibit good antibacterial activity was epiristocetin aglycone (an analogue with the 1'amino group in the opposite configuration (S) as ristocetin). On the basis of NMR studies of epiristocetin aglycone in solution, the 1'-amino group is located in the proposed carboxylate binding pocket and may sterically block complex formation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032439     DOI: 10.1021/jm00147a047

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.

Authors:  P Arriaga; J Laynez; M Menendez; J Cañada; F Garcia-Blanco
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

2.  Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms.

Authors:  D A Beauregard; A J Maguire; D H Williams; P E Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  A carrier protein strategy yields the structure of dalbavancin.

Authors:  Nicoleta J Economou; Virginie Nahoum; Stephen D Weeks; Kimberly C Grasty; Isaac J Zentner; Tracy M Townsend; Mohammad W Bhuiya; Simon Cocklin; Patrick J Loll
Journal:  J Am Chem Soc       Date:  2012-03-01       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.